Evidence map›Paper›PMID 39337497›Full record

ArticleInternational journal of molecular sciences2024

MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention.

Ainoa Navarrete-Pérez, Sara Gómez-Melero, Begoña Mª Escribano, Alejandro Galvao-Carmona, Cristina Conde-Gavilán, Mª Ángeles Peña-Toledo, Noelia Villarrubia, Luisa Mª Villar, Isaac Túnez, Eduardo Agüera-Morales and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ainoa Navarrete-PérezMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.
Sara Gómez-MeleroMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0003-1465-7110
Begoña Mª EscribanoMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-0966-0641
Alejandro Galvao-CarmonaMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-5126-1273
Cristina Conde-GavilánMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0003-3633-1146
Mª Ángeles Peña-ToledoMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.
Noelia VillarrubiaImmunology Department, Hospital Universitario Ramón y Cajal, Red Española de Esclerosis Múltiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, IRYCIS, 28034 Madrid, Spain.ORCID 0000-0002-2114-8632
Luisa Mª VillarImmunology Department, Hospital Universitario Ramón y Cajal, Red Española de Esclerosis Múltiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, IRYCIS, 28034 Madrid, Spain.ORCID 0000-0002-9067-3668
Isaac TúnezMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.
Eduardo Agüera-MoralesMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.
Javier Caballero-VillarrasoMaimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0003-0571-5147

Funding

Grant for neurological research SAN (Andalusian Society of Neurology)-2022
6 · The paper itself

Abstract

There is substantial evidence supporting the neuroprotective effects of the MIND diet in neurodegenerative diseases like Parkinson's and Alzheimer's. Our aim was to evaluate the impact of a nutritional intervention (NI) with this diet on multiple sclerosis (MS) patients. The study was conducted in two stages. In the first stage, two groups were included: MS patients before the NI (group A) and healthy control subjects (group B). In this stage, groups (A) and (B) were compared (case-control study). In the second stage, group (A) was assessed after the NI, with comparisons made between baseline and final measurements (before-and-after study). In the case-control stage (baseline evaluation), we found significant differences in fatigue scores (

Indexed as

Brain-Derived Neurotrophic FactorMultiple SclerosisAdultCase-Control StudiesFemaleGlutathioneHumansMaleMiddle AgedOxidative StressBDNF protein, humanBrain-Derived Neurotrophic FactorGlutathionedietary interventionfatiguelifestylesMIND dietmultiple sclerosisneurofilamentsneurotrophic factorsoxidative stressquality of lifeserum biomarkers

Identifiers

PMID39337497
PMCPMC11431943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.